Vaccines Conference Dubai 2019
 
Conference | Home
Welcome
Download Brochure
About Conference
OCM Members
Scientific Tracks
Abstract Submission
Important Dates
Register
Venue
Program
Sponsors
Policy

About the Conference

Citations International invites all the various members from the Pharmacy Spectrum to come back and participate during this elite and data bound conference. it's a scientific platform to follow and build networks and kind connections with fellow key decision makers from well-rounded the academic institutions, health care Institutes, Pharmaceutical, Biotech, CROs supply chain, provision practitioners making the conference a perfect platform to share experience, foster collaborations through the analysis talks & displays to put forward many thought provocative ways in which. it's a decent stage to brainstorm, discover new concepts, search for new skills and a platform to means your capabilities and discoveries to the world. The conference focuses on current and analysis bound topics like DNA Vaccines, Vaccines safety, HPV Vaccine, HIV Vaccines, Pneumococcal vaccine and many of extra. Which is able to for sure cause you to stunned and spell certain and can create your expertise learning and unforgettable one?

Vaccines and Vaccination 2019 will be one of the biggest events in the domain of Vaccines.

 

 

 

Why to attend?

Students from round the world centered on learning concerning Vaccines & medical specialty and its advances; this is often the most effective opportunity to succeed in the most important assemblage of participants from the Vaccines & medical specialty community. It give a certain platform for displays, distribute info, meet with current and potential scientists, build a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the foremost recent techniques, developments, and also the newest updates in Vaccines & medical specialty ar hallmarks of this conference. As vaccination care actions to a bigger patient targeted version, it turns into terribly vital to form positive associate adequate and skilled pharmacy exercise. Pharmacists, in one hand, need to form bond most use of their skills with the help of embarking on the way of lifetime of womb-to-tomb about to apprehend. However, it'll become evident that each one member of the attention system need to co-operate to form positive preparing, implementation, and pursuit of a therapeutic arrange that focuses on effective patient final results. Citations International pharmacy conference reinforces the importance of collaboration and communicates between policy manufacturers, stakeholders, regulators, pharmaceutical consultants and pharmacy technicians.

Importance and Scope of Vaccines:

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing micro-organism and is often made from weakened or killed forms of the microbe, its toxins are one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these micro-organisms that it later encounters.

Targeted Audience:

 

  • Researchers
  • Noble laureates in Health Care and Medicine
  • Vaccination Laboratories
  • Training institutes
  • Researchers & Scientists related to Vaccine R&D
  • Directors, CEOs, Presidents and Vice Presidents
  • University Faculty
  • Medical Schools/Colleges
  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Students
  • Scientists
  • Nursing Schools/Colleges
  • Associations and Societies related to Vaccine R&D
  • Vaccination Programme Organising Government and Non-government Organisations
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Manufacturing Companies
  • Vaccine Developers and Investigators

 

 

Market Report:

 

The vaccines market is expected to reach USD 49.27 Billion by 2022 from USD 32.31 Billion in 2016 at a CAGR of 7.5%. The study estimates the vaccines market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the vaccine market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the global market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from Markets and presented in this report. Based on technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines live attenuated vaccines, recombinant vaccines, and toxic vaccines. In 2017, the conjugate segment is expected to account for the largest share of the vaccines market. The growth in this market is mainly driven by increasing investments by the government of developing countries and rising prevalence of infectious diseases.

Based on disease indication, the pneumococcal segment is projected to grow at the highest CAGR during the forecast period.

By disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), Varicella, polio, dengue, and other disease indications. The pneumococcal segment is expected to register the highest rate during the forecast period. The growth in this segment can primarily be attributed to the increasing government investments in pneumococcal vaccination programs and high prevalence of pneumococcal disease.

The vaccines market is highly competitive with the presence of several small and big players. Some of the players in the vaccines market are GlaxoSmithKline plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi Pasteur SA (France), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Astellas Pharma Inc. (Japan), Serum Institute of India (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), and Daiichi Sankyo Company, Limited (Japan).

 

 

Venue